CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $169,111 | +28.7% | 13,379 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $131,382 | -1.3% | 13,379 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $133,121 | +12.6% | 13,379 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $118,270 | +124.2% | 13,379 | +49.1% | 0.00% | +100.0% |
| Q3 2019 | $52,761 | -51.0% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $107,676 | -0.6% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $108,304 | -3.8% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $112,611 | -15.4% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $133,159 | -11.8% | 8,973 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $151,000 | -26.3% | 8,973 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $205,000 | -11.6% | 8,973 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $232,000 | – | 8,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |